Product ID:775 MOISTURE SHIELD (AEROSOL)
MSDS Date:01/15/1988
FSC:6850
NIIN:00N044666
MSDS Number: BTMDS

A W CHESTERTON CO

MIDDLESEX INDUSTRIAL PARK RT 93
STONEHAM, MA 02180
US

Emergency Phone: 617-438-7000

Info Phone: 617-438-7013

Cage: 71431

CHESTERTON A W CO

STONEHAM, MA 02180-9101 US

Telephone: 781-438-7000/800-535-5053

Cage: 71431

<10

CAS: 8052-41-3

RTECS: WJ8925000

Fraction By Weight: 1-5%

OSHA PEL 100 PPM

ACGIH TLV: 100 PPM

0.6

CAS: 111-76-2

RTECS: KJ8575000

Fraction By Weight: 1-5%

OSHA PEL 25 PPM, S

ACGIH TLV: 25 PPM, S

ETHANE, 1,1,1-TRICHLORO-; (METHYL CHLOROFORM) (SARA III).

CAS: 71-55-6

RTECS: KJ2975000

Fraction By Weight: 75-80%

OSHA PEL 350 PPM;450 STEL

ACGIH TLV: 350 PPM;450 STEL

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

CARBON DIOXIDE

CAS: 124-38-9

RTECS: FF6400000

Fraction By Weight: 1-5%

OSHA PEL 10000 PPM;30000 STEL

ACGIH TLV: 5000 PPM;30000 STEL

ASSOCIATED WITH THE ADMINISTRATION OF ETHYLENE

RTECS: 9999999ZZ

(NIOSH) PUBLICATION NO. 90-118).

RTECS: 9999999ZZ

LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE: DIRECT CNTCT CAN CAUSE SKIN &
EYE IRRIT. INHAL OF VAP CONC IN EXCESS OF 1000 PPM MAY RESULT IN
DIZZINESS AND HEADACHE AND IN EXTREME CASES (10,000 PPM), LOSS OF
CONSCIOUSNESS. 2-BUTOXYETHANOL P ENETRATES THE SKIN READILY AND IS
MODERATELY TOXIC. CHRONIC: PROLONGED OR REPEATED SKIN CNTCT MAY
CAUSE(EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT
Effects of Overexposure:HLTH HAZ: SKIN IRRITATION AND MAY DEFAT SKIN.
RPTD OVEREXP TO 2-BUTOXYETHANOL MAY RESULT IN ERYTHOCYTE HEMOLYSIS,
LIVER AND KIDNEY EFFECTS. CHLOROCARBON MATLS HAVE PRODUCED SENSIT
OF THE MYOCARDIUM TO EPINEPHRINE IN LAB ANIMALS AND COULD HAVE
SIMILAR EFTS IN HUMANS. ADRENOMIMETICS (E.G. EPINEPHRINE) MAY BE
(SUPP DATA)
Medical Cond Aggravated by Exposure:PERSONNEL WITH ACUTE & CHRONIC
LIVER DISEASE AND RHYTHM DISORDERS OF THE HEART ARE GENERALLY
AGGRAVATED BY EXPOSURE.

First Aid:INHAL: REMOVE TO FRESH AIR. IF NOT BREATHING, ADMINSTER ARTF
RESP. DO NOT ADMIN ADRENALIN (EPINEPHRINE). CONTACT PHYSICIAN.
EYE/SKIN: WASH SKIN W/SOAP & WATER. FLUSH EYES FOR @ LST 15 MIN
W/LRG AMTS O F WATER. CONTACT MD IF IRRIT PERSISTS. INGEST: DO NOT
INDUCE VOMIT. CONTACT PHYSICIAN IMMEDIATELY.

Flash Point Method:CC
Flash Point:>199F,>93C
Extinguishing Media:CARBON MONOXIDE, DRY CHEMICAL, FOAM OR WATER SPRAY.
Fire Fighting Procedures:COOL EXPOSED CONTAINERS WITH WATER.
RECOMMENDED FIREFIGHTERS WEAR NIOSH/MSHA APPROVED PRESSURE DEMAND
SCBA AND FULL PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:PRESSURIZED CONTAINERS WHEN HEATED ARE A
POTENTIAL EXPLOSIVE HAZARD. THERMAL DECOMP CAN FORM HYDROGEN
CHLORIDE & OTHER TOXIC FUMES. THERMAL DECOMP (SUPP DATA)

Spill Release Procedures:EVACUATE AREA. PROVIDE ADEQ VENT. CONTAIN
SPILL TO A SMALL AREA. FLUSH AWAY FROM IGNTION SOURCES WITH WATER.
PICK UP WITH ABSORBENT MATL (E.G. SAND, ETC.) AND TRANSFER TO A
SUITABLE CONTAINER FOR DISP OSAL.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling and Storage Precautions:DO NOT STORE IN DIRECT SUNLIGHT OR
ABOVE 49C (120F).
Other Precautions:WASH CONTAMINATED CLOTHING BEFORE REUSE. NO SMOKING
IN AREA OF USE. DO NOT USE IN THE GENERAL VICINITY OF ARC WELDING,
OPEN FLAMES OR HOT SURFACES. HEAT AND/OR UV RADIATION MAY CAUSE THE
FORMATION OF HCL AND/OR PHOSGENE .

Respiratory Protection:NOT NORMALLY NEEDED. IF PEL/TLV IS EXCEEDED, USE
NIOSH/MSHA APPROVE SUPPLIED AIR RESPIRATOR.
Ventilation:NO SPECIAL REQUIREMENTS. IF PEL/TLV IS EXCEEDED, PROVIDE
ADEQUATE VENTILATION.
Protective Gloves:IMPERVIOUS GLOVES.
Eye Protection:ANSI APPVD SFTY GLSES OR GOGGLES .
Other Protective Equipment:IMPERVIOUS CLOTHING AS NECESSARY FOR
REPETITIVE, PROLONGED CONTACT WITH LIQUID.
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
EXPLO HAZ: PRODS MAY INCLUDE HCL & PHOSGEN . EFTS OF OVEREXP:
CONTRAINDICATED EXCEPT FOR LIFE-SUSTAINING USES IN HUMANS ACUTELY
OR CHRONICALLY EXPOSED TO CHLOROCARBONS . ANIMAL STUDIES HAV E
CLEARLY DEMONSTRATED DOSE-RELATED ADVERSE HLTH EFTS ON THE CNS,
HEMATOPOIETIC TISSUE, BLOOD, KIDNEY & LIVER (ING 5)

Boiling Pt:B.P. Text:165F,74C
Vapor Pres:SEE ING
Vapor Density:>1
Spec Gravity:1.2
Evaporation Rate & Reference:< 1 (ETHER =1)
Appearance and Odor:NONE SPECIFIED BY MANUFACTURER.
Percent Volatiles by Volume:85

Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZERS LIKE LIQUID CHLORINE AND CONCENTRATED OXYGEN.
Stability Condition to Avoid:OPEN FLAMES AND RED HOT SURFACES.
Hazardous Decomposition Products:HYDROGEN CHLORIDE AND OTHER TOXIC
FUMES. PHOSGENE .

Waste Disposal Methods:INCINERATE ABSORBED MATL. DO NOT INCINERATE
SEALED OR PRESSURIZED CONTAINERS. BURY CONTAINERS IN AN APPROVED
AREA. CHECK LOCAL, STATE AND FEDERAL REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.